Literature DB >> 31609289

Oncogenic Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Ryan C DeCoster1, Brian D Rinker2, Timothy A Butterfield3, Henry C Vasconez4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31609289      PMCID： PMC6935400          DOI： 10.1097/PRS.0000000000006331

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN： 0032-1052            Impact factor:   5.169


× No keyword cloud information.
  5 in total

1.  "A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma": The Supplement.

Authors:  Rod J Rohrich
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

Review 2.  Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Piers Blombery; Ella R Thompson; H Miles Prince
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

Review 3.  Theories of Etiopathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Pratik Rastogi; Edward Riordan; David Moon; Anand K Deva
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

Review 4.  New insights into breast implant-associated anaplastic large cell lymphoma.

Authors:  Camille Laurent; Corinne Haioun; Pierre Brousset; Philippe Gaulard
Journal:  Curr Opin Oncol       Date:  2018-09       Impact factor: 3.645

5.  Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Marshall E Kadin; Anand Deva; Haiying Xu; John Morgan; Pranay Khare; Roderick A F MacLeod; Bruce W Van Natta; William P Adams; Garry S Brody; Alan L Epstein
Journal:  Aesthet Surg J       Date:  2016-03-15       Impact factor: 4.283
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.